Nobiletin

Overview

Nobiletin (5,6,7,8,3',4'-hexamethoxyflavone) is a polymethoxylated flavone (PMF) found at high concentrations in the peel of citrus fruits, particularly Citrus depressa (shikuwasa/flat lemon), Citrus reticulata (tangerine/mandarin), and Citrus sinensis (sweet orange). Structurally, nobiletin is distinguished by six methoxy groups on its flavone backbone, which confer exceptional lipophilicity, metabolic stability, and oral bioavailability compared to hydroxylated flavonoids like quercetin or fisetin. This methylation pattern allows nobiletin to resist Phase II conjugation (glucuronidation and sulfation) that typically limits flavonoid bioavailability, enabling it to achieve pharmacologically relevant tissue concentrations through oral supplementation.

The most distinctive pharmacological property of nobiletin is its ability to enhance circadian clock function. Research by the Bhatt Bhatt lab at the Salk Institute demonstrated that nobiletin acts as an agonist of the ROR (retinoic acid receptor-related orphan receptor) family of nuclear receptors — specifically ROR-alpha and ROR-gamma — which are critical positive regulators of the core circadian clock gene BMAL1. By amplifying circadian oscillations, nobiletin restores disrupted metabolic rhythms in high-fat diet-fed mice, protecting against obesity, insulin resistance, hepatic steatosis, and atherosclerosis even without changes in caloric intake. This circadian mechanism positions nobiletin uniquely among metabolic compounds, as it addresses the temporal dimension of metabolism rather than simply modifying metabolic pathways. The anti-inflammatory effects are mediated through suppression of NF-kB, inhibition of iNOS and COX-2, and reduction of MMP-9 — all with potency exceeding that of most dietary flavonoids.

Neuroprotective research on nobiletin has generated substantial interest. The compound enhances hippocampal long-term potentiation (LTP) and memory formation through activation of the PKA-ERK-CREB signaling cascade, and demonstrates protective effects in animal models of Alzheimer's disease by reducing amyloid-beta accumulation, tau hyperphosphorylation, and neuroinflammation. Studies in 3xTg-AD mice showed significant cognitive improvement and reduction of both amyloid and tau pathology. Anti-cancer research has identified nobiletin as an inhibitor of angiogenesis, MMP-mediated invasion, and multiple oncogenic signaling pathways. Typical supplemental doses range from 100–500 mg daily, often derived from citrus peel extracts standardized for PMF content. Nobiletin pairs well with other circadian and metabolic compounds including berberine, resveratrol, and melatonin. Side effects are rare and mild at recommended doses.

Mechanism of Action

Nobiletin is a polymethoxylated flavone (5,6,7,8,3',4'-hexamethoxyflavone) found predominantly in citrus peel that acts on multiple molecular targets. Its primary mechanism involves direct activation of ROR-alpha and ROR-gamma (retinoic acid receptor-related orphan receptors), which are nuclear receptors functioning as transcription factors for circadian clock genes. Nobiletin enhances the amplitude of circadian rhythms by promoting ROR-mediated transcription of Bmal1, a core circadian clock component, thereby strengthening the molecular clock and improving metabolic homeostasis through circadian-dependent regulation of lipid metabolism, glucose handling, and energy expenditure.

Nobiletin potently inhibits the NF-kB and MAPK inflammatory signaling pathways by suppressing phosphorylation of IKK, JNK, ERK, and p38 kinases. It activates AMPK (AMP-activated protein kinase), which phosphorylates and inactivates ACC (acetyl-CoA carboxylase), promoting fatty acid oxidation while suppressing lipogenesis through SREBP-1c downregulation. Nobiletin inhibits PDE (phosphodiesterase) activity, increasing intracellular cAMP levels that activate PKA and CREB signaling, promoting BDNF expression and synaptic plasticity relevant to cognitive function. It also inhibits MMP-2/MMP-9 matrix metalloproteinases and VEGF expression, contributing to anti-angiogenic and anti-metastatic properties.

Therapeutically, nobiletin's unique circadian clock-enhancing activity positions it as a novel approach to metabolic syndrome, as circadian disruption is mechanistically linked to obesity, diabetes, and cardiovascular disease. Preclinical studies demonstrate protection against high-fat diet-induced obesity, atherosclerosis, and cognitive decline in Alzheimer's models (through reduced tau phosphorylation via GSK-3beta inhibition and amyloid-beta reduction). Its high oral bioavailability among flavonoids (due to polymethoxylation enhancing lipophilicity and metabolic stability) and multi-target pharmacology make it a promising candidate for age-related metabolic and neurodegenerative conditions.

Reconstitution Calculator

Research

Safety Profile

Nobiletin is generally well-tolerated with minimal reported side effects at typical doses. It may interact with cytochrome P450 enzymes and could alter the metabolism of certain medications, particularly statins and blood thinners. Long-term human safety data is limited, and caution is advised during pregnancy and breastfeeding.

Pharmacokinetic Profile